iRadimed Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,340.10
15,653.10
31,593.70
32,496.50
23,081.60
30,439
Cost of Goods Sold (COGS) incl. D&A
2,853.40
3,404.40
5,840.40
6,154.80
5,569.90
7,211.60
Gross Income
8,486.70
12,248.70
25,753.30
26,341.70
17,511.70
23,227.40
SG&A Expense
5,699.50
8,982.30
14,184.70
15,421.70
16,226.70
17,223.60
EBIT
2,787.20
3,065.90
11,568.60
10,920.10
1,285.00
6,003.80
Unusual Expense
-
-
55.40
-
-
-
Non Operating Income/Expense
3.50
48.60
27.50
93.70
11.20
44.60
Pretax Income
2,783.80
3,017.30
11,634.50
10,952.70
1,396.40
6,197.30
Income Tax
846.90
967.00
4,104.60
3,738.20
896.60
106.10
Consolidated Net Income
1,936.90
2,050.40
7,529.90
7,214.50
499.80
6,303.50
Net Income
1,936.90
2,050.40
7,529.90
7,214.50
499.80
6,303.50
Net Income After Extraordinaries
1,936.90
2,050.40
7,529.90
7,214.50
499.80
6,303.50
Net Income Available to Common
1,936.90
2,050.40
7,529.90
7,214.50
499.80
6,303.50
EPS (Basic)
0.22
0.20
0.60
0.60
0.04
0.52
Basic Shares Outstanding
7,000.00
8,743.50
11,003.30
10,818.40
10,638.90
10,758.80
EPS (Diluted)
0.22
0.20
0.60
0.60
0.04
0.52
Diluted Shares Outstanding
8,624.30
10,219.10
12,556.90
11,989.70
11,720.30
12,110.10
EBITDA
2,926.30
3,215.00
11,792.50
11,168.40
1,730.30
6,563.50
Other Operating Expense
-
200.50
-
-
-
-
Non-Operating Interest Income
-
-
148.90
126.40
122.60
238.10
About iRadimed
View Profile
